INmune Bio to attend 2026 Maxim Growth Summit
Bitget2026/10/06 13:03INmune Bio will attend the Maxim Growth Summit on Oct. 12-14, 2026, at the Hard Rock Hotel NYC. CEO David Moss is scheduled to present on an Immunology & Inflammation Therapies panel on Oct. 14 at 10:30 a.m. Management plans one-on-one meetings with institutional investors during the conference. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060900PRIMZONEFULLFEED9839545) on October 06, 2026, and is solely responsible for the information contained therein.
- INmune Bio will attend the Maxim Growth Summit on Oct. 12-14, 2026, at the Hard Rock Hotel NYC.
- CEO David Moss is scheduled to present on an Immunology & Inflammation Therapies panel on Oct. 14 at 10:30 a.m.
- Management plans one-on-one meetings with institutional investors during the conference.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.
Crypto prices
More
